Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

被引：37
|
作者：
Price, CP
Allard, J
Davies, G
Dawnay, A
Duffy, MJ
France, M
Mandarino, G
Ward, AM
Patel, B
Sibley, P
Sturgeon, C
机构：
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Clin Biochem, London E1 2AD, England
[2] Bayer Grp Diagnost, Tarrytown, NY 10591 USA
[3] Wrexham Maelor Hosp, Dept Biochem Med, Wrexham LL13 7TD, Clwyd, Wales
[4] Barts & London NHS Trust, Dept Clin Biochem, London EC1A 7BE, England
[5] St Vincents Hosp, Dept Nucl Med, Dublin 4, Ireland
[6] Manchester Royal Infirm, Dept Chem Pathol, Manchester M13 9WL, Lancs, England
[7] Abbott Labs, Abbott Pk, IL 60064 USA
[8] No Gen Hosp NHS Trust, Dept Immunol, Sheffield S5 7YT, S Yorkshire, England
[9] Euro DPC Ltd, Llanberis LL55 4EL, Caerns, Wales
[10] Royal Infirm, Dept Clin Biochem, Edinburgh EH3 9YW, Midlothian, Scotland
来源：
ANNALS OF CLINICAL BIOCHEMISTRY | 2001年 / 38卷
关键词：
D O I：
10.1258/0004563011900632
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：188 / 216
页数：29
相关论文
共 50 条
  • [11] On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
    Bangma, Chris H.
    van Schaik, Ron H.
    Blijenberg, Bert G.
    Roobol, Monique J.
    Lilja, Hans
    Stenman, Ulf-Hakan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3109 - 3119
  • [12] Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening
    Li, Jun
    Zhao, Guixiang
    Hall, Ingrid J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 49 (02) : 259 - 263
  • [13] Prostate-specific antigen screening for prostate cancer: A decision-analytical perspective
    Barry, Michael J.
    Kantoff, Philip W.
    Stahl, James E.
    BJU INTERNATIONAL, 2007, 100 (03) : 486 - 488
  • [14] Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
    Duffy, Michael J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 310 - 316
  • [15] Prostate-specific antigen for prostate cancer screening - Do physician characteristics affect its use?
    Edlefsen, KL
    Mandelson, MT
    McIntosh, MW
    Andersen, MR
    Wagner, EH
    Urban, N
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1999, 17 (01) : 87 - 90
  • [16] Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening Reply
    Miller, David C.
    Hollenbeck, Brent K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (13): : 1373 - 1374
  • [17] Serum prostate-specific antigen screening for prostate cancer: Analysis of the costs and benefits
    Mermershtain, W.
    Bone, D.
    Shteiman, T.
    Ariad, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [18] A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer
    Palma, Anton
    Lounsbury, David W.
    Schlecht, Nicolas F.
    Agalliu, Ilir
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2016, 183 (03) : 227 - 236
  • [19] Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits
    Candas, B
    Labrie, F
    Gomez, JL
    Cusan, L
    Chevrette, E
    Lévesque, J
    Brousseau, G
    JOURNAL OF UROLOGY, 2006, 175 (02): : 510 - 516
  • [20] Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening
    Loeb, Stacy
    EUROPEAN UROLOGY, 2012, 61 (05) : 875 - 876
12345